PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Dec 11, 2024 8-K
10-Q Nov 6, 2024 10-Q
8-K Nov 6, 2024 8-K
8-K Oct 24, 2024 8-K
4 Oct 7, 2024 PRIMARY DOCUMENT
8-K Sep 13, 2024 8-K
8-K Sep 9, 2024 8-K
10-Q Aug 12, 2024 10-Q
8-K Aug 12, 2024 8-K
4 Jul 8, 2024 PRIMARY DOCUMENT
4 Jun 18, 2024 4
4 Jun 18, 2024 PRIMARY DOCUMENT
4 Jun 18, 2024 PRIMARY DOCUMENT
4 Jun 18, 2024 PRIMARY DOCUMENT
4 Jun 18, 2024 PRIMARY DOCUMENT
4 Jun 18, 2024 PRIMARY DOCUMENT
8-K Jun 18, 2024 8-K
8-K Jun 12, 2024 8-K
EFFECT Jun 10, 2024
CORRESP Jun 6, 2024
UPLOAD Jun 3, 2024
S-3 May 30, 2024 S-3
8-K/A May 16, 2024 8-K/A
4 May 16, 2024 PRIMARY DOCUMENT
EFFECT May 8, 2024
← Newer Page 5 of 16 · 389 filings Older →